Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers.

Stephens D, Leston J, Terrault NA, Gailloux K, Mera J, Essex W, Reilley B.

J Public Health Manag Pract. 2019 Sep/Oct;25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years:S97-S100. doi: 10.1097/PHH.0000000000001061.

PMID:
31348196
2.

Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality.

Brandman D, Terrault NA.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):277-279. doi: 10.21037/hbsn.2019.01.07. No abstract available.

3.

Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.

Zhou K, Terrault NA.

Clin Gastroenterol Hepatol. 2019 Jun 4. pii: S1542-3565(19)30598-1. doi: 10.1016/j.cgh.2019.05.047. [Epub ahead of print]

PMID:
31173892
4.

Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.

Sharpton SR, Maraj B, Harding-Theobald E, Vittinghoff E, Terrault NA.

Am J Clin Nutr. 2019 May 24. pii: nqz042. doi: 10.1093/ajcn/nqz042. [Epub ahead of print]

PMID:
31124558
5.

Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation.

Giard JM, Dodge JL, Terrault NA.

Liver Transpl. 2019 Sep;25(9):1310-1320. doi: 10.1002/lt.25485. Epub 2019 Jul 24.

PMID:
31063642
6.

Telemedicine: An Evolving Field in Hepatology.

Piao C, Terrault NA, Sarkar S.

Hepatol Commun. 2019 Mar 25;3(5):716-721. doi: 10.1002/hep4.1340. eCollection 2019 May.

7.

Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.

Lee BP, Samur S, Dalgic OO, Bethea ED, Lucey MR, Weinberg E, Hsu C, Rinella ME, Im GY, Fix OK, Therapondos G, Han H, Victor DW, Voigt MD, Eswaran S, Terrault NA, Chhatwal J.

Gastroenterology. 2019 Aug;157(2):472-480.e5. doi: 10.1053/j.gastro.2019.04.012. Epub 2019 Apr 15.

PMID:
30998988
8.

Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.

Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF; Hepatitis B Research Network (HBRN).

PLoS Pathog. 2019 Apr 18;15(4):e1007715. doi: 10.1371/journal.ppat.1007715. eCollection 2019 Apr.

9.

Novel NS5B Resistance-Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy.

Catalli L, Martens SK, Terrault NA, Reeves JD.

Clin Liver Dis (Hoboken). 2019 Mar 29;13(3):74-78. doi: 10.1002/cld.768. eCollection 2019 Mar. Review. No abstract available.

10.

Return to Alcohol Use After Liver Transplant: Patterns and Surveillance.

Lee BP, Terrault NA.

Clin Liver Dis (Hoboken). 2019 Jan 2;12(6):160-164. doi: 10.1002/cld.756. eCollection 2018 Dec. Review. No abstract available.

11.

Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. doi: 10.1002/cld.728. eCollection 2018 Jul. Review. No abstract available.

12.

Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise.

Lee BP, Terrault NA.

Transl Gastroenterol Hepatol. 2019 Mar 22;4:19. doi: 10.21037/tgh.2019.03.04. eCollection 2019. No abstract available.

13.

Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database.

Lee BP, Im GY, Rice JP, Weinberg E, Hsu C, Fix OK, Therapondos G, Han H, Victor DW, Eswaran S, Maddur H, Terrault NA.

Liver Transpl. 2019 May;25(5):706-711. doi: 10.1002/lt.25448. Epub 2019 Mar 29.

PMID:
30882995
14.

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2019 Feb 8. pii: S1542-3565(19)30143-0. doi: 10.1016/j.cgh.2019.02.005. [Epub ahead of print]

PMID:
30743006
15.

Hepatitis C elimination: challenges with under-diagnosis and under-treatment.

Terrault NA.

F1000Res. 2019 Jan 14;8. pii: F1000 Faculty Rev-54. doi: 10.12688/f1000research.15892.1. eCollection 2019. Review.

16.

National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.

Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA.

JAMA Intern Med. 2019 Mar 1;179(3):340-348. doi: 10.1001/jamainternmed.2018.6536.

17.

Reply.

Terrault NA, Hassanein TI.

Gastroenterology. 2019 Feb;156(3):825-826. doi: 10.1053/j.gastro.2019.01.024. Epub 2019 Jan 16. No abstract available.

PMID:
30659833
18.

HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition.

Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2019 Jan 7. pii: S1542-3565(19)30012-6. doi: 10.1016/j.cgh.2018.12.039. [Epub ahead of print]

PMID:
30630104
19.

Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease.

Sharpton SR, Yong GJM, Terrault NA, Lynch SV.

Hepatol Commun. 2018 Dec 3;3(1):29-43. doi: 10.1002/hep4.1284. eCollection 2019 Jan. Review.

20.

Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care.

Kushner T, Terrault NA.

Hepatol Commun. 2018 Nov 30;3(1):20-28. doi: 10.1002/hep4.1282. eCollection 2019 Jan. Review.

21.

Outcomes of Sleeve Gastrectomy in Obese Liver Transplant Candidates.

Sharpton SR, Terrault NA, Posselt AM.

Liver Transpl. 2019 Apr;25(4):538-544. doi: 10.1002/lt.25406. Epub 2019 Mar 12.

22.

Prior Bariatric Surgery in Liver Transplant Candidates: Unforeseen Consequences?

Sharpton SR, Terrault NA.

Liver Transpl. 2019 Feb;25(2):203-204. doi: 10.1002/lt.25401. No abstract available.

23.

Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.

Lee BP, Vittinghoff E, Hsu C, Han H, Therapondos G, Fix OK, Victor DW, Dronamraju D, Im GY, Voigt MD, Rice JP, Lucey MR, Eswaran S, Chen PH, Li Z, Maddur H, Terrault NA.

Hepatology. 2019 Apr;69(4):1477-1487. doi: 10.1002/hep.30478. Epub 2019 Mar 5.

PMID:
30561766
24.

Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.

Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network.

Hepatology. 2019 Jun;69(6):2338-2348. doi: 10.1002/hep.30417. Epub 2019 Mar 14.

PMID:
30549279
25.

Care of Patients Following Cure of Hepatitis C Virus Infection.

Terrault NA.

Gastroenterol Hepatol (N Y). 2018 Nov;14(11):629-634.

26.

Reply.

Lee BP, Im GY, Lucey MR, Terrault NA.

Gastroenterology. 2019 Jan;156(1):286-287. doi: 10.1053/j.gastro.2018.11.044. Epub 2018 Nov 22. No abstract available.

PMID:
30472234
27.

New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.

Coffin CS, Zhou K, Terrault NA.

Gastroenterology. 2019 Jan;156(2):355-368.e3. doi: 10.1053/j.gastro.2018.11.037. Epub 2018 Nov 22. Review.

PMID:
30472225
28.

Evaluating Women's Preferences for Hepatitis C Treatment During Pregnancy.

Kushner T, Cohen J, Tien PC, Terrault NA.

Hepatol Commun. 2018 Oct 1;2(11):1306-1310. doi: 10.1002/hep4.1264. eCollection 2018 Nov.

29.

Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women.

Ajmera VH, Terrault NA, VanWagner LB, Sarkar M, Lewis CE, Carr JJ, Gunderson EP.

J Hepatol. 2019 Jan;70(1):126-132. doi: 10.1016/j.jhep.2018.09.013. Epub 2018 Nov 1.

30.

Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button?

Kwong AJ, Terrault NA.

Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):5-6. doi: 10.1038/s41575-018-0071-0. No abstract available.

PMID:
30333527
31.

Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B: One of These Things Is Not Like the Other.

Flemming JA, Terrault NA.

JAMA Oncol. 2019 Jan 1;5(1):17-18. doi: 10.1001/jamaoncol.2018.4039. No abstract available.

PMID:
30267036
32.

A changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over!

Terrault NA, Pageaux GP.

J Hepatol. 2018 Oct;69(4):767-768. doi: 10.1016/j.jhep.2018.07.020. Epub 2018 Aug 10. No abstract available.

PMID:
30104027
33.

Reply.

Terrault NA, Brown RS Jr, Lok AS, Wong JB, Bzowej NH, Chang KM, Hwang JP, Jonas MM, McMahon BJ.

Hepatology. 2018 Oct;68(4):1658-1660. doi: 10.1002/hep.30137. No abstract available.

PMID:
30070717
34.

Tenofovir to Prevent Perinatal Transmission of Hepatitis B.

Terrault NA, Feld JJ, Lok ASF.

N Engl J Med. 2018 Jun 14;378(24):2348-9. doi: 10.1056/NEJMc1805396. No abstract available.

PMID:
29900725
35.

Racial and Ethnic Differences in Graft Loss Among Female Liver Transplant Recipients.

Dave S, Dodge JL, Terrault NA, Sarkar M.

Transplant Proc. 2018 Jun;50(5):1413-1423. doi: 10.1016/j.transproceed.2018.02.059.

36.

Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series.

Campos-Varela I, Agudelo EZ, Terrault NA.

Clin Transplant. 2018 Jul;32(7):e13303. doi: 10.1111/ctr.13303. Epub 2018 Jun 25.

PMID:
29851150
37.

Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.

Terrault NA.

Hepatology. 2018 Nov;68(5):2035-2038. doi: 10.1002/hep.30047. Epub 2018 Oct 8. No abstract available.

PMID:
29672896
38.

Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.

Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA.

Gastroenterology. 2018 Aug;155(2):422-430.e1. doi: 10.1053/j.gastro.2018.04.009. Epub 2018 Apr 12.

39.

Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.

VanWagner LB, Ning H, Allen NB, Siddique J, Carson AP, Bancks MP, Lewis CE, Carr JJ, Speliotes E, Terrault NA, Rinella ME, Vos MB, Lloyd-Jones DM.

Liver Int. 2018 Nov;38(11):2069-2081. doi: 10.1111/liv.13747. Epub 2018 Apr 24.

PMID:
29608255
40.

Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.

Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS; Hepatitis B Research Network (HBRN); Harvard Consortium.

Diabetes Care. 2018 Jun;41(6):1251-1259. doi: 10.2337/dc18-0040. Epub 2018 Mar 29.

41.

Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.

Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA.

Hepatology. 2018 Aug;68(2):449-461. doi: 10.1002/hep.29855. Epub 2018 May 16.

42.

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800. No abstract available.

43.

Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus.

Lee BP, Terrault NA.

Curr Opin Organ Transplant. 2018 Apr;23(2):229-236. doi: 10.1097/MOT.0000000000000507. Review.

44.

Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis.

Hameed B, Terrault NA, Gill RM, Loomba R, Chalasani N, Hoofnagle JH, Van Natta ML; NASH CRN.

Aliment Pharmacol Ther. 2018 Mar;47(5):645-656. doi: 10.1111/apt.14492. Epub 2018 Jan 14.

45.

Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.

Lim JK, Liapakis AM, Shiffman ML, Lok AS, Zeuzem S, Terrault NA, Park JS, Landis CS, Hassan M, Gallant J, Kuo A, Pockros PJ, Vainorius M, Akushevich L, Michael L, Fried MW, Nelson DR, Ben-Ari Z; HCV-TARGET Study Group.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1811-1819.e4. doi: 10.1016/j.cgh.2017.12.037. Epub 2018 Jan 3.

PMID:
29306043
46.

Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.

Campos-Varela I, Agudelo EZ, Sarkar M, Roberts JP, Terrault NA.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12809. Epub 2018 Jan 3.

47.

Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.

VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB.

Liver Int. 2018 Apr;38(4):706-714. doi: 10.1111/liv.13603. Epub 2017 Oct 13.

48.

Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.

Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, Burton JR Jr, Terrault NA, Fox AN, DiMartini AF.

Transplantation. 2018 Jan;102(1):105-118. doi: 10.1097/TP.0000000000001942.

49.

Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.

Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA.

Transplantation. 2017 Sep;101(9):2079-2082. doi: 10.1097/TP.0000000000001786.

PMID:
28880197
50.

Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.

VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J.

Gastroenterology. 2017 Nov;153(5):1260-1272.e3. doi: 10.1053/j.gastro.2017.08.012. Epub 2017 Aug 9.

Supplemental Content

Loading ...
Support Center